Addex Therapeutics Ltd
ADXN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7,056 | -$10,556 | -$20,804 | -$15,352 |
| Dep. & Amort. | $260 | $306 | $323 | $348 |
| Deferred Tax | $0 | $0 | $0 | -$151 |
| Stock-Based Comp. | $0 | $1,794 | $3,682 | $1,178 |
| Change in WC | -$1,228 | $214 | $158 | -$762 |
| Other Non-Cash | -$11,461 | $250 | $204 | $33 |
| Operating Cash Flow | -$5,374 | -$7,992 | -$16,437 | -$14,705 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$7 | -$1 | -$32 |
| Net Acquisitions | -$473 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $4 | $1 |
| Other Inv. Act. | $5,120 | $0 | $0 | $0 |
| Investing Cash Flow | $4,645 | -$7 | $3 | -$30 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$74 | -$282 | -$288 | -$310 |
| Stock Issued | $241 | $2,351 | $1,676 | $13,958 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$62 | $3,196 | $1,715 | $2,754 |
| Financing Cash Flow | $105 | $5,265 | $3,103 | $16,403 |
| Forex Effect | $100 | -$357 | -$196 | $122 |
| Net Chg. in Cash | -$524 | -$3,092 | -$13,528 | $1,790 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,865 | $6,957 | $20,485 | $18,695 |
| End Cash | $3,342 | $3,865 | $6,957 | $20,485 |
| Free Cash Flow | -$5,375 | -$7,999 | -$16,438 | -$14,737 |